The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
Completed · Phase 4
Conditions studied: Gastroesophageal Reflux Disease, Bronchopulmonary Dysplasia
In brief
The purpose of this study is to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
Key facts
- Study ID
- NCT00926276
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 2
- Starts
- 2009-06-01
- Expected to finish
- 2013-05-01
- Last updated by the study team
- 2014-12-11
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must meet all inclusion criteria for Initial Evaluation of GERD
- Positive pH-MII test for GERD
- Upper GI contrast radiograph to evaluate for associated congenital gastrointestinal anomalies
- > or = 2 kg (due to technical limitations of fundoplication)
You may not qualify if…
- Previous intra-abdominal surgery except for gastrostomy
- Those deemed not surgical candidates
- Infants with associated congenital gastrointestinal anomalies
- > or = 1 year of age at time of Initial Evaluation of GERD
Where it is running
- UT-Houston Pediatric Surgery & Memorial Hermann Children's Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.